An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Crohn's Disease
Related studies linked through entity extraction aliases.
Cell Surface Marker Expression in Autoimmune Diseases
- Status
- COMPLETED
- Phase
- N/A
A Study of E6011 in Participants With Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs
- Status
- UNKNOWN
- Phase
- N/A
Specific microRNAs as Potential Biomarker for Inflammatory Bowel Disease
- Status
- UNKNOWN
- Phase
- NA
A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study
- Status
- COMPLETED
- Phase
- N/A
An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE2
Pilot Study of an Online Therapeutic Education Program for Patients With Inflammatory Bowel Disease
- Status
- UNKNOWN
- Phase
- NA
Efficacy and Safety of TD-1473 in Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)
- Status
- TERMINATED
- Phase
- PHASE3
An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)
- Status
- TERMINATED
- Phase
- PHASE3
Blood and Stool Molecular Biomarkers Longitudinal Detection Study in Crohn's Disease (CD) Patients
- Status
- TERMINATED
- Phase
- NA
CUP Certolizumab Pegol (CDP-870) in Adults Suffering From Crohn's Disease (CD)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)
- Status
- TERMINATED
- Phase
- PHASE3
Upper Gastrointestinal Lesions in Crohn's Disease
- Status
- UNKNOWN
- Phase
- NA
A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients With Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE1
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Proteomic Analysis of Crohn's Disease Macrophages in Response or Not to AIEC
- Status
- COMPLETED
- Phase
- N/A